Quadrivalent Influenza Vaccine, No Preservative — Competitive Intelligence Brief

Quadrivalent Influenza Vaccine, No Preservative (Quadrivalent Influenza Vaccine, No Preservative) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated influenza vaccine. Area: Immunology.

phase 3 Inactivated influenza vaccine Immunology Biologic

Target snapshot

Quadrivalent Influenza Vaccine, No Preservative (Quadrivalent Influenza Vaccine, No Preservative) — Sanofi Pasteur, a Sanofi Company. This vaccine stimulates the immune system to produce antibodies against four strains of influenza virus, providing protection against seasonal flu infection.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Quadrivalent Influenza Vaccine, No Preservative TARGET	Quadrivalent Influenza Vaccine, No Preservative	Sanofi Pasteur, a Sanofi Company	phase 3	Inactivated influenza vaccine
TIV	TIV	Folia Biotech Inc.	marketed	Inactivated influenza vaccine
Fluad alone	Fluad alone	Korea University Guro Hospital	marketed	Inactivated influenza vaccine with adjuvant	Influenza virus hemagglutinin and neuraminidase antigens; MF59 acts as immunological adjuvant
Standard Dose Quadrivalent Influenza Vaccine	Standard Dose Quadrivalent Influenza Vaccine	Hospital Israelita Albert Einstein	marketed	Inactivated influenza vaccine
Standard-Dose Influenza Vaccine	Standard-Dose Influenza Vaccine	Tor Biering-Sørensen	marketed	Inactivated influenza vaccine
FluarixTM	FluarixTM	GlaxoSmithKline	marketed	inactivated influenza vaccine
Fluzone High-Dose vaccine	Fluzone High-Dose vaccine	Sanofi Pasteur, a Sanofi Company	marketed	inactivated influenza vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated influenza vaccine class)

1. GlaxoSmithKline · 16 drugs in this class
2. Seqirus · 5 drugs in this class
3. Sanofi Pasteur, a Sanofi Company · 5 drugs in this class
4. Green Cross Corporation · 4 drugs in this class
5. Novartis · 2 drugs in this class
6. SK Chemicals Co., Ltd. · 2 drugs in this class
7. Sanofi · 2 drugs in this class
8. Hospital Israelita Albert Einstein · 2 drugs in this class
9. McGill University Health Centre/Research Institute of the McGill University Health Centre · 2 drugs in this class
10. Il-Yang Pharm. Co., Ltd. · 2 drugs in this class